Abeona Therapeutics
ABEO
54 hedge funds and large institutions have $72M invested in Abeona Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 4 closing their positions.
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
73% more capital invested
Capital invested by funds: $41.6M → $72M (+$30.4M)
38% more funds holding
Funds holding: 39 → 54 (+15)
1.49% more ownership
Funds ownership: 0% → 1.49% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $126K | Put options by funds: $138K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.2M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$9.91M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.16M |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$6.26M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Soros Fund Management
New York
|
-$3.54M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.09M |
| 3 |
RA
Royce & Associates
New York
|
-$392K |
| 4 |
Goldman Sachs
New York
|
-$354K |
| 5 |
RI
RTW Investments
New York
|
-$116K |
ABEO Hedge Fund Activity: Q4 2016 in Review
54 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2016, worth a combined $72M — up 73% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ABEO positions and 4 closed out — a net gain of 16 holders — while 17 added to existing stakes and 9 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $12.2M. The largest seller was Soros Fund Management, cutting an estimated $3.54M.
- 54 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2016, up from 39 in Q3 2016.
- Funds reported $72M of Abeona Therapeutics stock for Q4 2016, up 73% quarter-over-quarter.
- 20 funds opened new Abeona Therapeutics positions in Q4 2016 and 4 closed out, a net change of +16 holders.
- The largest Abeona Therapeutics buyer in Q4 2016 was Adage Capital Partners, an estimated $12.2M added.
- The largest Abeona Therapeutics seller in Q4 2016 was Soros Fund Management, an estimated $3.54M sold.
Based on aggregated 13F filings for Q4 2016.